PT  - JOURNAL ARTICLE
AU  - Atkinson, Barry
AU  - van Veldhoven, Karin
AU  - Nicholls, Ian
AU  - Coldwell, Matthew
AU  - Clarke, Adam
AU  - Frost, Gillian
AU  - Atchison, Christina J.
AU  - Raja, Amber I.
AU  - Bennett, Allan M
AU  - Morgan, Derek
AU  - Pearce, Neil
AU  - Fletcher, Tony
AU  - Brickley, Elizabeth B
AU  - Chen, Yiqun
TI  - An outbreak of SARS-CoV-2 in a public-facing office in England, 2021
AID  - 10.1101/2022.01.31.22269194
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.01.31.22269194
4099  - http://medrxiv.org/content/early/2022/02/01/2022.01.31.22269194.short
4100  - http://medrxiv.org/content/early/2022/02/01/2022.01.31.22269194.full
AB  - Between August-September 2021, an outbreak of SARS-CoV-2, with an attack rate of 55% (22/40 workers), occurred in a public-facing office in England. To identify workplace and worker-related risk factors, a comprehensive investigation involving surface sampling, environmental assessment, molecular and serological testing, and worker questionnaires was performed in September – October 2021. The results affirm the utility of surface sampling to identify SARS-CoV-2 control deficiencies and the importance of evolving, site-specific risk assessments with layered COVID-19 mitigation strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by funding from the PROTECT COVID-19 National Core Study on Transmission and Environment, managed by the Health and Safety Executive on behalf of HM Government.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NHS North East Research Ethics Committee of the NHS gave ethical approval for this work (20/NE/0282)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors